Recombinant BRD7 antibody (AA 150-200)

Catalog No. ABIN7449350

The Rabbit Monoclonal anti-BRD7 antibody has been validated for WB and FACS. It is suitable to detect BRD7 in samples from Human and Mouse.

Quick Overview for Recombinant BRD7 antibody (AA 150-200) (ABIN7449350)

Target: BRD7 (Bromodomain Containing 7 (BRD7))

Antibody Type: Recombinant Antibody

Reactivity: Human, Mouse

Host: Rabbit

Clonality: Monoclonal

Conjugate: This BRD7 antibody is un-conjugated

Application: Western Blotting (WB), Flow Cytometry (FACS)

Clone: BLR220K

Product Details anti-BRD7 Antibody

Binding Specificity: AA 150-200

Purpose: Rabbit anti-BRD7 Recombinant Monoclonal Antibody [BLR220K]

Immunogen: between AA 150 and 200

Isotype: IgG

Application Details

Application Notes: 01:01,00

Restrictions: For Research Use only

Handling

Concentration: 500 μg/mL

Buffer: Borate Buffered Saline (BBS) pH 8.2 with 0.1 % BSA and 0.09 % Sodium Azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Expiry Date: 12 months

Target Details for BRD7

Target: BRD7 (Bromodomain Containing 7 (BRD7))

Alternative Name: BRD7

Background: Background: Bromodomain-containing protein 7 was identified in a two-hybrid screen as an interactor of interferon regulatory factor-2 (IRF-2) and called CELTIX1. BRD7 was also identified as a binding partner of disheveled-1 (Dvl-1) and found to play a role in Wnt signaling and the regulation of glycogen synthase kinase 3-beta activity. Recently, BRD7 was identified as a subunit of the polybromo-associated BRG1-associated factor (PBAF) complex and shown to be required for the modulation of transcription in embryonic stem cells.

Gene ID: 29117

NCBI Accession: NP_037395

UniProt: Q9NPI1